Other frontotemporal neurocognitive disorder
ICD-10 G31.09 is a billable code used to indicate a diagnosis of other frontotemporal neurocognitive disorder.
Other frontotemporal neurocognitive disorder encompasses a range of conditions characterized by progressive degeneration of the frontal and temporal lobes of the brain, leading to significant cognitive decline. Unlike Alzheimer's disease, which primarily affects memory, frontotemporal disorders often manifest with changes in personality, behavior, and language. Patients may exhibit impulsivity, social withdrawal, and emotional blunting. The onset is typically earlier than Alzheimer's, often occurring in individuals in their 50s or 60s. Diagnosis is primarily clinical, supported by neuroimaging studies that reveal atrophy in the frontal and temporal regions. Cognitive assessments may show deficits in executive function, language skills, and social cognition. Given the overlap with other neurodegenerative diseases, accurate diagnosis is crucial for appropriate management and care planning.
Detailed neurological examination findings, neuroimaging results, and cognitive assessment scores.
Patients presenting with personality changes, language difficulties, or executive dysfunction.
Ensure clear documentation of symptom onset and progression to support diagnosis.
Comprehensive psychiatric evaluation, including history of behavioral changes and mental status examination.
Patients with mood changes, social withdrawal, or impulsive behavior.
Differentiate from primary psychiatric disorders to avoid misdiagnosis.
Used to assess cognitive function in patients suspected of having frontotemporal neurocognitive disorder.
Document the specific tests performed and the results.
Neurologists and psychologists should collaborate on assessment.
Key symptoms include changes in personality, behavior, language difficulties, and executive dysfunction. Patients may exhibit impulsivity, social withdrawal, and emotional blunting.
Diagnosis is primarily clinical, supported by neuroimaging and cognitive assessments. It is important to differentiate it from other neurocognitive disorders, particularly Alzheimer's disease.
